May 22: A Move To Shift Part B Rx Into Part D Would Anger Oncologists, Cancer Patients
If the administration were to propose shifting drugs covered by Medicare Part B into the Part D drug reimbursement system, the move would spark a blitz of opposition from cancer doctors and patients, and hospitals might also push back hard if the policy were accompanied by changes to the 340B drug discount program, lobbyists say.
May 22: A Move To Shift Part B Rx Into Part D Would Anger Oncologists, Cancer Patients
If the administration were to propose shifting drugs covered by Medicare Part B into the Part D drug reimbursement system, the move would spark a blitz of opposition from cancer doctors and patients, and hospitals might also push back hard if the policy were accompanied by changes to the 340B drug discount program, lobbyists say.
